Illumina Inc (ILMN)

205.06
+17.82(+9.52%)
After Hours
204.10
-0.96(-0.47%)
- Real-time Data
  • Volume:
    2,714,334
  • Day's Range:
    195.05 - 207.14
  • 52 wk Range:
    173.45 - 428.00

ILMN Overview

Prev. Close
187.24
Day's Range
195.05-207.14
Revenue
4.69B
Open
196.48
52 wk Range
173.45-428
EPS
-0.129
Volume
2,714,334
Market Cap
32.26B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,599,289
P/E Ratio
-1,530.59
Beta
1.16
1-Year Change
-52.58%
Shares Outstanding
157,300,000
Next Earnings Date
24 Oct 2022
What is your sentiment on Illumina?
or
Market is currently closed. Voting is open during market hours.

Illumina Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Illumina Inc Analysis

Illumina Inc Company Profile

Illumina Inc Company Profile

Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The Company's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Read More

Analyst Price Target

Average259.38 (+26.49% Upside)
High380
Low175
Price205.06
No. of Analysts17
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsStrong BuyBuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • these guys are *the* DNA sequencing company of the future. they've just won a bunch of patent lawsuits to protect their proprietary technology going forward, have been granted emergency approval by the FDA to help combat Covid and are going to have their machines in half the research labs and universities in the world. I'm excited for how this one will develop over the coming years as biotech booms
    1
    • hi
      0
      • ILLUMINA is going to punch a hole in the sky tonight !!! all the way back to 380‼️ SOON
        0